Insecticides (india) Limited · NSE:INSECTICID
Insecticides (india) — Q3 FY2021 Earnings Presentation
18 slides from Insecticides (india)'s earnings presentation, Feb 1, 2021
Slide 1: Q3 FY2021 Earnings Presentation
(BSE: 532851 NSE: INSECTICID) Q3 FY2021 Earnings Presentation
Slide 2: Q3 FY2021 Highlights
Q3 FY2021 Highlights Revenue from Operations (Rs. Mn) EBITDA (Rs. Mn) Profit after Tax (Rs. Mn) 2,992 2,629 230 86 151 60 8.7% 3.3% 5.0% 2.0% Q3 FY20 Q3 FY21 Q3 FY20 Q3 FY21 Q3 FY20 Q3 FY21 EBITDA Margin (%) PAT Margin (%) Quarter Highlights: • Revenue from operations increased by 13.8% on y-o-y bas
Slide 3: 9M FY2021 Highlights
9M FY2021 Highlights Revenue from Operations (Rs. Mn) EBITDA (Rs. Mn) Profit after Tax (Rs. Mn) 11,246 11,646 1,583 1,236 14.1% 934 715 10.6% 8.3% 6.1% 9M FY20 9M FY21 9M FY20 9M FY21 9M FY20 9M FY21 EBITDA Margin (%) PAT Margin (%) Nine Months Highlights: • Revenue from operations increased by 3.6%
Slide 4: Management Commentary
Management Commentary Commenting on the results, Mr. Rajesh Aggarwal, Managing Director, said: “Agriculture and agrochemicals sector in the third quarter of the fiscal year witnessed wide-ranging factors at play, on one hand the sector saw healthy demand in major crops, on the other, unseasonal rain
Slide 5: Products Freshness Index
Products Freshness Index Proven track record of successful new product launches exhibits IIL’s strong R&D capabilities and continues to provide competitive edge 571 535 Gross Revenue from new product launches (Rs. Cr.) 30 478 70 90 404 420 66 89 59 23 131 36 299 148 92 90 66 11 9 13 9 221 33 45 21 3
Slide 6: Growth Strategy
Growth Strategy R& D will results in New product Phase out Generic Products Exports launches in Maharatna Category • Focus on in-house R&D and international • Working on registration in new • Phasing out the Generic Products (high partners to launch new products countries with 100+ export agreements
Slide 7: Capabilities and Geographical Presence
Capabilities and Geographical Presence R&D Manufacturing • NABL QC Labs • 5 Formulations plant • In-house R&D Centre 01 02 • 2 Technical synthesis plants • JV with OAT Agrio Co. • 1 Biological manufacturing plant* Japan for dedicated R&D Centre Development Marketing & Training 04 03 • Sale & market
Slide 8: Leading Maharatna Brands
Leading Maharatna Brands LETHAL : Organo-phosphorus group of insecticides; controls insects through contact, stomach and vapour action HERCULES Hercules is a broad-spectrum insecticide for control of sucking pests in crops like Cotton, Chillies etc. PULSOR : Systemic fungicide with preventive and cu
Slide 9: Research & Development
Research & Development State-of-the-art in house R&D centre established in 2005, augmented by product innovation R&D center, formulation R&D centre and biological R&D centre • Approved by DSIR, Ministry of Science and Technology 12 Patents Received • Working on new formulations and new combination p
Slide 10: Business Overview
Business Overview Insecticides India - A Leading Agro Chemicals Manufacturing Company Engaged in the manufacturing and marketing of crop-protection products Rs. 1,165 Cr 60,000+ Four product categories: Insecticides, Herbicides, Fungicides, 9M FY21 Sales Retail Outlets Biologicals and Plant Growth R
Slide 11: Financial Performance
Financial Performance Q3 Y-o-Y Q2 Q-o-Q Nine Months Y-o-Y (Rs. Million) FY2021 FY2020 Growth(%) FY2021 Growth(%) FY2021 FY2020 Growth(%) Operating Revenue 2,992 2,629 13.8% 4,558 (34.4)% 11,646 11,246 3.6% Other Income 10 8 33.1% 50 (79.6)% 56 35 60.8% Total Revenue 3,002 2,636 13.9% 4,609 (34.9)% 1
Slide 12: Financial Trends - Quarterly
Financial Trends - Quarterly Revenue from Operations (Rs. Mn) EBITDA (Rs. Mn) Profit after Tax (Rs. Mn) 4,558 4,096 577 2,992 492 414 2,629 2,387 241 230 12.0% 12.7% 151 9.0% 8.7% 86 5.9% 60 (25) 5.0% 3.3% (73) (1.0)% 2.0% Q3 FY20 Q4 FY20 Q1 FY21 Q2 FY21 Q3 FY21 Q3 FY20 Q4 FY20 Q1 FY21 Q2 FY21 Q3 FY
Slide 13: Financial Trends - Annual
Financial Trends - Annual Strong Revenue and profitability growth in last 5 years Revenue from Operations (Rs. Mn) EBITDA (Rs. Mn) Profit after Tax (Rs. Mn) 8.4% 14.1% 21.4% CAGR CAGR CAGR 13,632 11,935 1,872 1,224 10,733 1,559 9,882 9,942 1,478 840 860 1,114 15.7% 920 13.8% 597 10.2% 11.2% 11.4% 39
Slide 14: Segment Reporting –9M FY2021
Segment Reporting –9M FY2021 Net Sales by Product Category Net Sales by Segment 9% 2% 4% 24% Insecticides 32% B2C 57% Herbicides 72% B2B Fungicides Exports PGR Net Sales vs Internal Consumption Breakdown of Top Seller Range in B2C Sales 49% 51% 51% 49% Maharatna Internal Products Consumption Other P
Slide 15: Segment Reporting –9M FY2021
Segment Reporting –9M FY2021 Net Sales by Segment (Rs. Mn) Net Sales by Emphasized Product Category (Rs. Mn) -1.0% +18.0% +14.2% +7.1% -7.6% 8,483 8,401 4,664 4,092 4,309 3,819 2,393 2,823 370 422 B2C B2B Exports Maharatna Products Other Products 9MFY20 9MFY21 9MFY20 9MFY21 • Growth in B2B and expor
Slide 16: 2021 Outlook
2021 Outlook Opportunities India is currently the world’s fourth largest producer of Quarterly Outlook agrochemicals. Normal monsoon and improved kharif Domestic rabi food grains production in the ongoing 2020-21 performance should drive growth. India’s current crop year is expected to be better tha
Slide 17: Disclaimer
Disclaimer This presentation contains statements that contain “forward looking statements” including, but without limitation, statements relating to the implementation of strategic initiatives, and other statements relating to Insecticides (India) Limited (“Insecticides (India)” or the Company) futu
Slide 18: Insecticides (India) Ltd. contact details
Insecticides (India) Ltd. (CIN: L65991DLl996PLC083909) 401-402, Lusa Tower Azadpur Commercial Complex Delhi - 110033 Telefax: +91 11 - 27679700 - 04 (5 Lines) info@insecticidesindia.com www.insecticidesindia.com
Insecticides (India) — Q3 FY2021 Earnings Presentation on 6ix